Dimensional Fund Advisors’s Century Therapeutics IPSC Stock Holding History

Dimensional Fund Advisors’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$544K	Buy	318,535 +47,043	+17%	+$96.4K	﹤0.01%	2933
2026 Q2	$665K	Buy	271,492 +216,309	+392%	+$494K	﹤0.01%	2935
2026 Q1	$122K	Buy	+55,183	New	+$116K	﹤0.01%	3102
2025 Q2	–	Sell	-26,735	Closed	-$12.8K	–	3299
2025 Q1	$12.8K	Sell	26,735 -139	-0.5%	-$104	﹤0.01%	3313
2024 Q4	$27.1K	Sell	26,874 -6,575	-20%	-$8.95K	﹤0.01%	3322
2024 Q3	$56.9K	Sell	33,449 -41,866	-56%	-$82K	﹤0.01%	3288
2024 Q2	$192K	Buy	75,315 +44,155	+142%	+$140K	﹤0.01%	3172
2024 Q1	$130K	Sell	31,160 -1,438	-4%	-$6.09K	﹤0.01%	3234
2023 Q4	$108K	Buy	32,598 +4,572	+16%	+$8.33K	﹤0.01%	3272
2023 Q3	$56.1K	Sell	28,026 -2,465	-8%	-$6.56K	﹤0.01%	3369
2023 Q2	$96.4K	Sell	30,491 -8,962	-23%	-$28.9K	﹤0.01%	3328
2023 Q1	$137K	Buy	+39,453	New	+$173K	﹤0.01%	3265
2022 Q3	$370K	Buy	+37,440	New	+$394K	﹤0.01%	3107

Other funds holding IPSC

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Parametrica Management Wanchai, Hong Kong $142M AUM 113.92% 1-Year Est. Return

Quadrant Private Wealth Management Center Valley, Pennsylvania $753M AUM 13.49% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Xponance Philadelphia, Pennsylvania $17.2B AUM 36.34% 1-Year Est. Return

Dimensional Fund Advisors's IPSC Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Century Therapeutics (IPSC) stake by 17% in Q3 2026, buying an estimated $96.4K and bringing the position to 318,535 shares worth $544K. The position accounts for ﹤0.01% of the portfolio, ranked #2933.

Dimensional Fund Advisors first reported a position in IPSC in Q3 2022 and has held it in 13 quarters since. The position peaked at $665K in Q2 2026. 22 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

Dimensional Fund Advisors held 318,535 shares of Century Therapeutics worth $544K as of Q3 2026.
Dimensional Fund Advisors bought 47,043 Century Therapeutics shares in Q3 2026, an estimated $96.4K.
Century Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2933 holding.
Dimensional Fund Advisors first reported a position in Century Therapeutics in Q3 2022 and has held it in 13 quarters since.
Dimensional Fund Advisors's Century Therapeutics position peaked at $665K in Q2 2026.
22 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.